| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.3 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.027 | 0.3 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |